Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

(NASDAQ: DXCM), the global leader in glucose biosensing, announced today the return of Dexcom U – its one-of-a-kind Name, ...

In a head-to-head study, three continuous glucose monitoring systems show different measurements in the same person, which ...

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...

SAN DIEGO – Dexcom is bringing back Dexcom U, a name, image and license program for college athletes with diabetes.

San Diego-based Dexcom, a leading diabetes technology company known for its wearable glucose monitors, is expanding its NIL ...

Mark Andrews breaks silence on playoff drop at fund raiser for his new NIL fund dedicated to athletes with diabetes.

Medtronic plc’s diabetes unit posted another win with the U.S. FDA approval of the Simplera continuous glucose monitoring sensor for use with the Minimed 780G pump system, helping the company catch up ...

Shares of DexCom Inc. DXCM slid 3.59% to $66.11 Monday, on what proved to be an all-around rough trading session for the ...

Medtronic initially won FDA approval in August for its next-generation Simplera CGM. The Simplera platform includes the ...

Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of DexCom, Inc. (NASDAQ: DXCM) for potential breaches of ...